These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 17066215

  • 1. Realistic expectations for treatment success in Alzheimer's disease.
    Geldmacher DS, Frolich L, Doody RS, Erkinjuntti T, Vellas B, Jones RW, Banerjee S, Lin P, Sano M.
    J Nutr Health Aging; 2006; 10(5):417-29. PubMed ID: 17066215
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.
    Di Santo SG, Prinelli F, Adorni F, Caltagirone C, Musicco M.
    J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Discontinuing Alzheimer's disease drug therapy: why, when, and how.
    Crutchfield D.
    Director; 2008; 16(1):19-21. PubMed ID: 19343870
    [Abstract] [Full Text] [Related]

  • 7. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
    Beier MT.
    Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
    [Abstract] [Full Text] [Related]

  • 8. Current treatments of Alzheimer disease: are main caregivers satisfied with the drug treatments received by their patients?
    Sevilla C, Jiménez Caballero PE, Alfonso V, González-Adalid M.
    Dement Geriatr Cogn Disord; 2009 Mar; 28(3):196-205. PubMed ID: 19738386
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.
    Harry RD, Zakzanis KK.
    Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322
    [Abstract] [Full Text] [Related]

  • 13. Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.
    Prasher VP.
    Int J Geriatr Psychiatry; 2004 Jun; 19(6):509-15. PubMed ID: 15211527
    [Abstract] [Full Text] [Related]

  • 14. Predicting time to nursing home placement based on activities of daily living scores--a modelling analysis using data on Alzheimer's disease patients receiving rivastigmine or donepezil.
    Hatoum HT, Thomas SK, Lin SJ, Lane R, Bullock R.
    J Med Econ; 2009 Jun; 12(2):98-103. PubMed ID: 19492974
    [Abstract] [Full Text] [Related]

  • 15. An open-label, comparative study of rivastigmine, donepezil and galantamine in a real-world setting.
    Aguglia E, Onor ML, Saina M, Maso E.
    Curr Med Res Opin; 2004 Nov; 20(11):1747-52. PubMed ID: 15537474
    [Abstract] [Full Text] [Related]

  • 16. Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment.
    Dantoine T, Auriacombe S, Sarazin M, Becker H, Pere JJ, Bourdeix I.
    Int J Clin Pract; 2006 Jan; 60(1):110-8. PubMed ID: 16409439
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Alzheimer's disease: Seeing the signs early.
    Leifer BP.
    J Am Acad Nurse Pract; 2009 Nov; 21(11):588-95. PubMed ID: 19900220
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.